The Effect of Thermotherapy on Recovery and Performance (Cryotherapy)

The Effect of Cryotherapy on Recovery and Performance: A Randomized Controlled Double Blind Trial

This study investigates the effects of cooling on the recovery and performance characteristic in young healthy subjects. The study is divided in two projects:

Project A: investigates the effects of 20 min. post-exercise cooling on vertical jump performance and delayed onset muscle soreness and rated perceived exertion.

Project B: investigates the effects of 20 min. pre-exercise cooling on maximal voluntary contraction of the right M. quadriceps femoris and delayed onset muscle soreness and rated perceived exertion.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to investigate the effects of a 20 min. external cooling application (+8°C ) versus a external thermo neutral application (+32°C) up to 72 hours post application.

The study is divided in two projects:

Project A: This study is focusing on the recovery process after a max. jump performance (3x30 counter movement jumps). Directly after the exercise subjects receive a cooling or thermo-neutral application. Recovery characteristics measured by vertical jump performance (objective) and delayed onset muscle soreness and rated perceived exertion (subjective) are measured in function of time up to 72 hours post cooling intervention.

Project B: This study is focusing on the effect of 20 min. cooling or thermo-neutral application on the M. quadriceps femoris performance (MVC). After the thermo-application, the 60% endurance MVC is measured by means of surface EMG (OT Bioelettronica 10-750 Hz) in a ergometer chair 90° degrees knee flexion (Cor 1 Bioelettronica). Muscle conduction velocity, MVC (objective), delayed onset muscle soreness and rated perceived exertion (subjective) are measured in function of time up to 72 hours post thermo-application.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kanton Graubünden
      • Landquart, Kanton Graubünden, Switzerland, 7302
        • University of Applied Sciences and Arts of Southern Switzerland SUPSI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • only healthy young subjects 18-30 years
  • no musculoskeletal surgery in trunk and lower extremities
  • injury history in trunk and lower extremity for more than one year
  • subjects taking anticonceptive medication are allowed to participate

Exclusion Criteria:

  • actual injuries or injuries for less than one year in trunk and /or lower extremities
  • injury history in trunk and lower extremity for more than one year with complaints
  • anxiety of cooling
  • subjects on medication
  • pace maker
  • cardiovascular disease
  • pregnancy
  • skeletal problems
  • appendectomy for less than two years
  • Morbus Raynaud syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cooling intervention
subjects in this study receive a single pre-exercise (3x MVC) or post-exercise intervention (3x 30 counter movement jumps), consisting of an external cooling application (Zamar Therapy CT clinic) applied to both thighs. Both interventions have a duration of 20 minutes and a temperature of 8°C
Zamar Therapy is a certified medical product (directive 93/42/EEC and ISO 134 85:2012) (www.zamarmedical.com)
Sham Comparator: thermoneutral intervention
subjects in the control group receive a single pre-exercise (3x MVC) or post-exercise (3x 30 counter movement jumps) sham intervention, consisting of a 20 minute external thermoneutral application (Zamar Therapy CT clinic) applied to both thighs. Both sham interventions have a duration of 20 minutes and a temperature of 32°C.
Zamar Therapy is a certified medical product (directive 93/42/EEC and ISO 134 85:2012) (www.zamarmedical.com)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delayed-onset Muscle Soreness (DOMS)
Time Frame: 72 hours
The subjective recovery characteristics "Delayed-onset muscle soreness (DOMS)" was rated on a 0-10 cm visual analog scale. DOMS was assessed in a squat position (90° knee angle, with brief holding of maximum 3 seconds) ranging from zero (no soreness) to ten (severe soreness). Higher values mean mean more DOMS and therefore less recovery.
72 hours
Ratings of Perceived Exertion (RPE)
Time Frame: 72 hours
The subjective recovery characteristics " Ratings of perceived exertion (RPE)" was rated on a 6-20 Borg scale (from 6 = "no exertion at all" to 20 = "Maximal exertion") in a standing position. The higher value means more exertion and therefore less recovery.
72 hours
Vertical Jump Performance (VJP)
Time Frame: 72 hours
Vertical jump performance (VJP) was assessed performing three maximal counter mouvemet jumps (CMJs) with a 30-second pause between the three jumps on the Just Jump system (Probotics Inc, Huntsville, AL, USA). The highest jump was recorded.
72 hours
Peak Power Output (PPO)
Time Frame: 72 hours
Peak power output (PPO) was assessed performing three maximal counter movement jumps (CMJs) on the Just Jump system (Probotics Inc, Huntsville, AL, USA) with a 30-second pause between the three jumps. PPO (presented in watts) was calculated.
72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 24 hours post cold application
Time Frame: 0-24 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 24 hours post cold application is evaluated
0-24 hours post cold application
The effect of a 20 minute cryotherapy application on delayed onset muscle soreness 48 hours post cold application
Time Frame: 24-48 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 48 hours post cold application is evaluated
24-48 hours post cold application
The effect of a 20 minute cryotherapy application on delayed onset muscle 72 hours post cold application
Time Frame: 48-72 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: delayed onset muscle soreness (V.A.S 0-10 cm) 72 hours post cold application is evaluated
48-72 hours post cold application
The effect of a 20 minute cryotherapy application on rated perceived exertion 24 hours post cold application
Time Frame: 0-24 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 24 hours post cold application is evaluated
0-24 hours post cold application
The effect of a 20 minute cryotherapy application on rated perceived exertion 48 hours post cold application
Time Frame: 24-48 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 48 hours post cold application is evaluated
24-48 hours post cold application
The effect of a 20 minute cryotherapy application on rated perceived exertion 72 hours post cold application
Time Frame: 48-72 hours post cold application
n= 20 subjects for subjective recovery. subjective recovery: rated perceived exertion (Borg scale 6-20) 72 hours post cold application is evaluated
48-72 hours post cold application

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ron Clijsen, PhD, University of Applied Sciences and Arts of Southern Switzerland SUPSI

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

November 1, 2018

Study Completion (Actual)

May 1, 2019

Study Registration Dates

First Submitted

May 27, 2015

First Submitted That Met QC Criteria

July 21, 2015

First Posted (Estimated)

July 23, 2015

Study Record Updates

Last Update Posted (Actual)

October 20, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Zamar Therapy CT clinic

Subscribe